Boston Foundation, Inc., 10% Owner at Flex Pharma, Inc. (FLKS), sold 337,000 shares at $0.37 ($125K) on 2019-01-09, disclosed to the SEC on 2019-01-10.
Open-market sale of $125k FLKS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |